Top

Breast Cancer Research and Treatment

Published in:

01-05-2001

Mammographic finding as predictor of survival in 1–9mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone

Authors: Erik Thurfjell, Mercidyl Gelig Thurfjell, Anders Lindgren

Published in: Breast Cancer Research and Treatment | Issue 2/2001

Title: Mammographic finding as predictor of survival in 1–9mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone
Authors: Erik Thurfjell
Mercidyl Gelig Thurfjell
Anders Lindgren
Publication date: 01-05-2001
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 2/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1010648919150

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2001

Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue

Corrigendum

Suppression of aromatase (estrogen synthetase) by red wine phytochemicals

Letter to the editor

Keynote webinar | Spotlight on antibody–drug conjugates in cancer